N-(4-(N-1,3,4-thiadiazol-2-ylsulfamoyl)phenyl)-2-(3-chloro-4-fluorophenyl)acetamide

ID: ALA3108870

PubChem CID: 73670805

Max Phase: Preclinical

Molecular Formula: C16H12ClFN4O3S2

Molecular Weight: 426.88

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Cc1ccc(F)c(Cl)c1)Nc1ccc(S(=O)(=O)Nc2nncs2)cc1

Standard InChI:  InChI=1S/C16H12ClFN4O3S2/c17-13-7-10(1-6-14(13)18)8-15(23)20-11-2-4-12(5-3-11)27(24,25)22-16-21-19-9-26-16/h1-7,9H,8H2,(H,20,23)(H,21,22)

Standard InChI Key:  DDCAUPBWFJKZDY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   10.8419   -8.7094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4248   -8.7151    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    9.8321   -8.0066    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0150   -8.0081    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1687  -10.3569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8789   -9.9448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5884  -10.3548    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2963   -9.9464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9989  -10.3568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7098   -9.9505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7098   -9.1296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9989   -8.7233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2962   -9.1296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8781   -9.1276    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4601   -9.9499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4637   -9.1349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7559   -8.7279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0481   -9.1382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0526   -9.9596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7609  -10.3628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3484  -10.3717    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   10.1333   -9.1224    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.5872   -9.0414    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.1335   -8.4297    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.7205   -7.7210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9190   -7.8949    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.3390   -8.7321    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  3  2  2  0
  2  4  2  0
  6  5  1  0
  7  6  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
  8 13  2  0
 11  2  1  0
  6 14  2  0
  5 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 19 21  1  0
  2 22  1  0
 22  1  1  0
  1 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26  1  1  0
 18 27  1  0
M  END

Associated Targets(Human)

Plasma (7708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsome (8277 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MRC5 (9203 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasma (6361 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsome (4459 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma brucei brucei (13300 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PFKM 6-phosphofructokinase, muscle type (5 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
pfk 6-phospho-1-fructokinase (7870 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
pfk 6-phospho-1-fructokinase, putative (79 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 426.88Molecular Weight (Monoisotopic): 426.0023AlogP: 3.31#Rotatable Bonds: 6
Polar Surface Area: 101.05Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 6.55CX Basic pKa: CX LogP: 2.74CX LogD: 2.09
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.63Np Likeness Score: -2.68

References

1. Brimacombe KR, Walsh MJ, Liu L, Vásquez-Valdivieso MG, Morgan HP, McNae I, Fothergill-Gilmore LA, Michels PA, Auld DS, Simeonov A, Walkinshaw MD, Shen M, Boxer MB..  (2014)  Identification of ML251, a Potent Inhibitor of T. brucei and T. cruzi Phosphofructokinase.,  (1): [PMID:24900769] [10.1021/ml400259d]
2. Miana GE, Ribone SR, Vera DMA, Sánchez-Moreno M, Mazzieri MR, Quevedo MA..  (2019)  Design, synthesis and molecular docking studies of novel N-arylsulfonyl-benzimidazoles with anti Trypanosoma cruzi activity.,  165  [PMID:30641409] [10.1016/j.ejmech.2019.01.013]

Source